The Genomic and Clinical Innovation Unit is a space conceived as a strategic alliance between the Translational Institute for Genomic Singularity (ITRASIG), Tecnológico de Monterrey (Mexico City Campus), and the Tlalpan Innovation District.
The purpose of this Unit is to promote research, innovation, and entrepreneurship in health and biotechnology, bringing cutting-edge science closer to people's lives.
The Unit seeks to position Mexico City as a benchmark in clinical and genomic innovation, strengthen technological sovereignty in health, and create solutions with direct social impact.